I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Derek W Russell, MD
University of Alabama at Birmingham Heersink School of Medicine
Principal Investigator - Kathleen D Liu, MD
University of California, San Francisco
Principal Investigator - Laura Esserman, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Uc Davis Medical Center
Davis, California, United States
- Uc Irvine Medical Center
Irvine, California, United States
- Long Beach Memorial Medical Center
Long Beach, California, United States
- Kaiser Lamc
Los Angeles, California, United States
- University of Southern California
Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- University of California San Francisco (ucsf)
San Francisco, California, United States
- University of Colorado
Aurora, Colorado, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Stamford Health
Stamford, Connecticut, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- University of Miami
Coral Gables, Florida, United States
- University of Florida
Gainesville, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Corewell Health
Grand Rapids, Michigan, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Kalispell Regional Medical Center
Kalispell, Montana, United States
- Logan Health Medical Center
Kalispell, Montana, United States
- Virtua Mount Holly Hospital
Mount Holly, New Jersey, United States
- Virtua Voorhees Hospital
Voorhees Township, New Jersey, United States
- Columbia University Medical Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- University Hospital Cleveland Medical Center
Cleveland, Ohio, United States
- University of Pennsylvania (u Penn)
Philadelphia, Pennsylvania, United States
- Lankenau Medical Center (mainline Health)
Wynnewood, Pennsylvania, United States
- Main Line Health - Lankenau Medical Center
Wynnewood, Pennsylvania, United States
- Sanford Health
Souix Falls, South Dakota, United States
- Dhr Health
Edinburg, Texas, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Wvu Medicine
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2020
- Primary completion
- 31 Jul 2028
- Completion
- 31 Jul 2030
- Last update posted
- 16 Mar 2026
- Registered enrollment
- 1,500
- Registry id
- NCT04488081
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.